Harnessing natural killer cells to develop next‐generation cellular immunotherapy

Cellular immunotherapy harnesses the body's own immune system to fight cancer by using engineered T cells, macrophages, or natural killer (NK) cells. Compared to chimeric antigen receptor T (CAR‐T) cells that are commonly used to treat hematological malignancies, CAR‐NK cells have shown remarka...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Siyao, Nguyen, Kaycee, Park, Dongyong, Wong, Nelson, Wang, Anson, Zhou, Yubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676120/
https://www.ncbi.nlm.nih.gov/pubmed/36420177
http://dx.doi.org/10.1002/cdt3.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676120/
https://www.ncbi.nlm.nih.gov/pubmed/36420177
http://dx.doi.org/10.1002/cdt3.40

Ejemplares similares